oligonucleotides (Genta/Geron)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameoligonucleotides (Genta/Geron)
Drug Alias Nameanticode (Genta/Geron)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenta Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenta IncorporatedGeron Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A